Accustem Sciences Inc. (ACUT)
USD 0.55
(14.58%)
USD 0.55
(14.58%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2022 | 3.74 Million USD | 458.66% |
| 2021 | 670.61 Thousand USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 Q1 | 833.34 Thousand USD | -14.84% |
| 2023 Q3 | 598.52 Thousand USD | 60.57% |
| 2023 Q2 | 372.75 Thousand USD | -55.27% |
| 2022 Q3 | 899.12 Thousand USD | -16.61% |
| 2022 Q2 | 1.07 Million USD | 36.39% |
| 2022 Q1 | 790.53 Thousand USD | 17.88% |
| 2022 FY | 3.74 Million USD | 458.66% |
| 2022 Q4 | 978.53 Thousand USD | 8.83% |
| 2021 Q4 | 670.61 Thousand USD | 0.0% |
| 2021 FY | 670.61 Thousand USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Burzynski Research Institute, Inc. | 1.33 Million USD | -180.54% |
| Arch Therapeutics, Inc. | 5.04 Million USD | 25.696% |
| Evofem Biosciences, Inc. | 29.55 Million USD | 87.323% |
| Nascent Biotech, Inc. | 2.22 Million USD | -68.01% |
| Rebus Holdings, Inc. | 664 Thousand USD | -464.22% |
| Santhera Pharmaceuticals Holding AG | 37.25 Million USD | 89.944% |
| Qrons Inc. | 643.67 Thousand USD | -482.034% |
| Adynxx, Inc. | - USD | -Infinity% |
| Neon Bloom, Inc. | 389.56 Thousand USD | -861.69% |
| Northwest Biotherapeutics, Inc. | 57.44 Million USD | 93.478% |
| ProtoKinetix, Incorporated | 415.47 Thousand USD | -801.711% |
| Skye Bioscience, Inc. | 13.54 Million USD | 72.346% |
| Eiger BioPharmaceuticals, Inc. | 86.78 Million USD | 95.683% |
| Nanobac Pharmaceuticals, Incorporated | 4.91 Million USD | 23.821% |
| Institute of Biomedical Research Corp. | 261.72 Thousand USD | -1331.428% |
| SQZ Biotechnologies Company | 85.61 Million USD | 95.624% |
| Intellipharmaceutics International Inc. | 2.91 Million USD | -28.468% |
| Propanc Biopharma, Inc. | 1.5 Million USD | -149.445% |
| Mesoblast Limited | 5.9 Million USD | 36.523% |
| Marizyme, Inc. | 19.23 Million USD | 80.528% |
| Genus plc | 147.7 Million USD | 97.463% |
| VioQuest Pharmaceuticals, Inc. | 8.77 Million USD | 57.326% |
| Pharming Group N.V. | 225.49 Million USD | 98.339% |
| Therapeutic Solutions International, Inc. | 2.04 Million USD | -82.868% |
| CNBX Pharmaceuticals Inc. | 1.34 Million USD | -179.262% |
| Nymox Pharmaceutical Corporation | 8.33 Million USD | 55.074% |
| ContraFect Corporation | 56.88 Million USD | 93.415% |
| PsyBio Therapeutics Corp. | 4.4 Million USD | 15.022% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 1.47 Million USD | -153.35% |
| IMV Inc. | 37.7 Million USD | 90.065% |
| AXIM Biotechnologies, Inc. | 2.79 Million USD | -34.263% |
| MultiCell Technologies, Inc. | 567.42 USD | -660155.014% |
| ONE Bio Corp. | 6.44 Million USD | 41.861% |
| RVL Pharmaceuticals plc | 85.94 Million USD | 95.641% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| EV Biologics, Inc. | 531.96 Thousand USD | -604.264% |
| Q BioMed Inc. | 3.43 Million USD | -9.014% |
| Emmaus Life Sciences, Inc. | 24.71 Million USD | 84.842% |
| Mosaic ImmunoEngineering Inc. | 2.62 Million USD | -42.584% |
| Biomind Labs Inc. | 994.18 Thousand USD | -276.834% |
| American Oriental Bioengineering, Inc. | 99.33 Million USD | 96.228% |
| Provectus Biopharmaceuticals, Inc. | 1.75 Million USD | -112.904% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Oncotelic Therapeutics, Inc. | 6.71 Million USD | 44.233% |
| GlobeStar Therapeutics Corporation | 1.86 Million USD | -100.948% |
| THC Farmaceuticals, Inc. | -25 Thousand USD | 15085.676% |
| Acro Biomedical Co., Ltd. | 16.01 Million USD | 76.6% |
| Curative Biotechnology, Inc. | 1.83 Million USD | -104.154% |
| GB Sciences, Inc. | 1.42 Million USD | -163.738% |
| Alpha Cognition Inc. | 9.7 Million USD | 61.399% |
| HST Global, Inc. | 140.9 Thousand USD | -2558.788% |
| CSL Limited | 3.44 Billion USD | 99.891% |
| Wesana Health Holdings Inc. | 1.12 Million USD | -233.042% |
| Halberd Corporation | 74.84 Thousand USD | -4905.771% |
| Enzolytics Inc. | 2.17 Million USD | -71.893% |
| Agentix Corp. | 1.37 Million USD | -173.111% |
| Resverlogix Corp. | 12.71 Million USD | 70.528% |
| Nuo Therapeutics, Inc. | 3.65 Million USD | -2.622% |
| MetaStat, Inc. | - USD | -Infinity% |
| argenx SE | 1.53 Billion USD | 99.756% |
| Enzon Pharmaceuticals, Inc. | 1.04 Million USD | -258.852% |
| Endonovo Therapeutics, Inc. | 2.4 Million USD | -55.781% |
| RespireRx Pharmaceuticals Inc. | 1.57 Million USD | -137.212% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | 3.4 Million USD | -10.028% |
| AVAX Technologies, Inc. | 7.31 Million USD | 48.751% |
| Zenith Capital Corp. | 8.94 Million USD | 58.108% |
| Genscript Biotech Corporation | 825.34 Million USD | 99.546% |
| Ember Therapeutics, Inc. | 17.42 Thousand USD | -21405.189% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 2.45 Million USD | -52.584% |
| WPD Pharmaceuticals Inc. | 171.5 Thousand USD | -2084.386% |
| Cotinga Pharmaceuticals Inc. | 1.92 Million USD | -95.034% |
| Kadimastem Ltd | 2.41 Million USD | -55.446% |
| Helix BioMedix, Inc. | 1.97 Million USD | -89.977% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 10.86 Million USD | 65.525% |
| BioStem Technologies, Inc. | 22.97 Million USD | 83.693% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Reve Technologies, Inc. | 181.48 Thousand USD | -1964.313% |
| LadRx Corporation | 3.81 Million USD | 1.715% |
| Cell Source, Inc. | 4.32 Million USD | 13.385% |
| Regen BioPharma, Inc. | 923.51 Thousand USD | -305.672% |
| Regen BioPharma, Inc. | 923.51 Thousand USD | -305.672% |
| NovAccess Global Inc. | 2.46 Million USD | -51.876% |
| Affymax, Inc. | 39.38 Million USD | 90.488% |
| Itoco Inc. | 919.14 Thousand USD | -307.599% |
| Rasna Therapeutics, Inc. | 4.23 Million USD | 11.608% |
| Pathfinder Cell Therapy, Inc. | 1.11 Million USD | -234.801% |
| Mobile Lads Corp. | 554.54 Thousand USD | -575.583% |
| CytoDyn Inc. | 18.05 Million USD | 79.253% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | 25.16 Thousand USD | -14785.053% |
| NanoSphere Health Sciences Inc. | 220.07 Thousand USD | -1602.314% |
| Alseres Pharmaceuticals, Inc. | 1.41 Million USD | -163.871% |
| SYBLEU INC | 160.87 Thousand USD | -2228.762% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | 1.81 Million USD | -106.264% |
| International Stem Cell Corporation | 5.27 Million USD | 28.924% |
| Bioxytran, Inc. | 3.82 Million USD | 1.93% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 52.64 Thousand USD | -7016.787% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | 20.34 Thousand USD | -18316.256% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 36.26 Million USD | 89.67% |
| Adhera Therapeutics, Inc. | 1.61 Million USD | -131.546% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 735.83 Thousand USD | -409.138% |
| Innovation Pharmaceuticals Inc. | 3.11 Million USD | -20.425% |
| Neutra Corp. | 243.82 Thousand USD | -1436.545% |
| Windtree Therapeutics, Inc. | 17.45 Million USD | 78.539% |
| PureTech Health plc | 144.59 Million USD | 97.409% |
| Coeptis Therapeutics, Inc. | 20.48 Million USD | 81.716% |
| IXICO plc | 4.7 Million USD | 20.407% |
| IntelGenx Technologies Corp. | 8.79 Million USD | 57.413% |
| Gelesis Holdings, Inc. | 117.74 Million USD | 96.818% |
| CSL Limited | 3.89 Billion USD | 99.904% |
| Cellectis S.A. | 97.32 Million USD | 96.15% |